Brendan J. Classon

1 Patent

• US122915712025

  Methods for Reducing Eosinophilic Infiltration by Administering an Anti-interleukin-4 Receptor (IL4R) Antibody

  Regeneron Pharmaceuticals, Inc.

  0 cites